Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Monitoring of Specific Birth Defects Associated With Exposure to Lamotrigine in Pregnancy Through the EUROCAT Network.

Next Previous
Trial Profile

Monitoring of Specific Birth Defects Associated With Exposure to Lamotrigine in Pregnancy Through the EUROCAT Network.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jul 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lamotrigine (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Acronyms EUROCAT
  • Sponsors GlaxoSmithKline; GSK

Most Recent Events

  • 29 Sep 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
  • 31 Aug 2012 Planned number of patients (1) added as reported by ClinicalTrials.gov record.
  • 03 Feb 2010 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top